UIC Study on Isagenix Earns Top Recognition at Scientific Conference
from Live Long, Live Healthy, by Isagenix
Exciting news! Isagenix is pleased to announce that the University of Illinois at Chicago (UIC) study that involved our Isagenix system is receiving excellent recognition within the field of nutrition science.
The UIC study’s abstract won the American Society for Nutrition (ASN) obesity research interest section abstract competition. In addition, the study was selected for an oral presentation in April at ASN’s annual meeting at the Experimental Biology conference in Boston.
Experimental Biology is one of the largest annual scientific conferences to take place in the world. The event brings together scientists and researchers from fields of anatomy, physiology, biochemistry, pathology, nutrition, and pharmacology to discuss strides and contributions in the field of science.
Isagenix Abstract Wins
“It’s very impressive that we won, considering the competition,” said Krista Varady, Ph.D., assistant professor at the UIC College of Applied Health Sciences and the study’s principal investigator. She explains that the abstract was chosen along with four others as winners among more than 100 abstracts submitted within the research interest section.
According to Isagenix Chief Science Officer Suk Cho, Ph.D., “It’s exciting and an honor for these researchers to receive this type of recognition. The study with Dr. Varady is novel with quality outcomes that make winning this obesity research interest competition well-deserved.”
Study Demonstated Clinical Validation for Isagenix System
The 10-week study demonstrated clear, clinical validation for the use of an Isagenix system, which showed superior results when compared with a “heart-healthy” dietary plan based on nationally recognized guidelines. Notably, the Isagenix system led to a 56 percent greater reduction in average weight loss, 47 percent greater reduction in average body fat loss, twice as much visceral fat loss, and 35 percent greater reduction of oxidative stress. The study subjects also reported greater adherence on the Isagenix plan and that they considered it convenient and easy to follow.
The study’s results were published in two peer-reviewed journals, Nutrition and Metabolism and Nutrition Journal. (Read more about the UIC study’s design and results by reading our“Clinical Research Summary” or viewing our “Isagenix in Comparison to ‘Heart Healthy’ Diet” flyer.)
Nicholas Messina, M.D., former medical director and principal investigator of numerous clinical trials, recently praised the study for its randomized, double-arm design, as well as its appropriate inclusion and exclusion criteria and clear objectives. He wrote, “The bottom line is that this is a well-designed, scientifically sound protocol that was carried out at a major university research center by a skilled, published researcher. This was not the common observational study that is often seen when evaluating nutritional products.”
Stay tuned! Representatives of Isagenix Research and Science are planning on being in Boston for the oral presentation in April, so you can be sure to expect a report here.